Patented Medicine Prices Review Board - Economic Action Plan 2012
| Functional area |
Planned Savings (In 000s) |
| 2012-13 |
2013-14 |
2014-15 &
Ongoing |
| Administrative Efficiencies and Rationalization of Structures and Functions (1) |
Reduction of funding for the Non-patented
Prescription Drug Prices Program |
144 |
311 |
374 |
| Streamlining Regulatory Operations and Administration (2) |
Reduction of the Special Purpose Allotment for
PMPRB Hearings |
630 |
630 |
630 |
| TOTAL - Patented Medicine Prices Review Board: |
774 |
941 |
1,004 |
Notes:
(1) This measure applies to the Pharmaceutical Trends Program program activity.
(2) This measure applies to the Patented Medicine Prices Regulation Program program activity.